Navigation Links
Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies
Date:6/16/2008

collect preliminary pharmacokinetic information on the metabolism of the agent to support expanded Phase II clinical trials.

About Fox Chase Cancer Center

Fox Chase Cancer Center is one of the leading cancer research and treatments centers in the United States. Founded in 1904 in Philadelphia as the nation's first cancer hospital, Fox Chase became one of the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, treatment, and community outreach.

About Olympus

Established in 1919, Olympus Corporation, Tokyo, Japan, manufactures and sells precision machinery and instruments for medical and healthcare, imaging and information, and industrial applications, whose core competency is opto-digital technology. With a focus on innovation and quality, Olympus Corporation is improving medical and healthcare services by developing molecular imaging system technology with Olympus Medical Systems Corp. for early detection and treatment of oncological diseases to better serve our customers' needs. Olympus Medical Systems Corp., a wholly owned subsidiary of Olympus Corporation, develops a wide range of medical equipment, including gastrointestinal endoscopes, minimally invasive surgical endoscopes, endoscope disposal equipment, ultrasonic endoscopes and other endotherapy products.

About VisEn Medical

VisEn Medical, Inc. was founded in 2000 based on fluorescence in vivo imaging technologies initially developed by industry-leading researchers and clinicians at the Massachusetts General Hospital and Harvard Medical School. VisEn develops and commercializes the industry's highest performing fluorescence in vivo imaging technology platforms, from research through medicine. The Company also works with large pharmaceutical partners to des
'/>"/>

SOURCE VisEn Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
2. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
3. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
4. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
5. New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients
6. Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
7. Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
8. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
9. Leading Academic Institutions Collaborate on 800-Patient Study of Effectiveness of Cryoablation for Men With Recurrent Prostate Cancer
10. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
11. Celator(R) Pharmaceuticals Announces Positive Phase 2 Results for CPX-1 in Treatment of Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 06, 2015 Research and Markets ... addition of the "Global Insulin Patch Market ... Highly advanced technology like ultrasound and iontophoresis ... insulin patches. Depending upon the type of technique, ... of reach of several patients. In long-term, it ...
(Date:5/6/2015)...   CEFALY Technology , the creators of the ... for use prior to the onset of migraine pain, ... at the EUROHEADPAIN - Midterm Meeting at the International ... , from May 14-17, 2015. On May ... major European research project focused on migraines, CEFALY ...
(Date:5/6/2015)... SAN ANTONIO , May 6, 2015   GenSpera, ... "Injectable Cancer Compositions" has entered the national phase application process ... , Eurasia, Japan , China ... the United States . When awarded, the resulting patent ... property around its entire platform technology, including its lead drug ...
Breaking Medicine Technology:Global Insulin Patch Market Opportunity Analysis 2015 2CEFALY to Present Breakthrough Data in Migraine Treatment at International Headache Society Congress 2GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations 2
... Therapy Reduces TNF-alpha Production Through Inhibition,of PDE-4 ... /PRNewswire/ -- Anacor,Pharmaceuticals, a privately held pharmaceutical ... Phase 1 trial of,AN2728, a first-in-class topical ... The trial showed AN2728 to be,well-tolerated, with ...
... and Pharmacokinetics Similar to IV Doses in,Phase ... 06, 2007 /PRNewswire-FirstCall/ --,Genta Incorporated announced the ... Company's lead anti-cancer drug,Genasense(R) (oblimersen sodium) injection, ... injection, as well,as by brief intravenous (IV) ...
Cached Medicine Technology:Anacor Clinical Study of AN2728, a Novel Anti-Inflammatory,Compound, Shows Efficacy in Psoriasis 2Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 2Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 3Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 4
(Date:5/6/2015)... Illinois (PRWEB) May 06, 2015 RPS Revolution ... take on the tried and true Rock Paper Scissors game ... With fun characters that encourage storytelling and easy to learn ... new twist on an old favorite. RPS Revolution ... it into whimsical characters that are grouped in set of ...
(Date:5/6/2015)... Imprivata ® (NYSE: IMPR), the ... Ting will lead a discussion about the Internet of ... user authentication challenges, during Citrix Synergy (May ... on the benefits of creating a network of IP-connected ... patients can share information. It will also emphasize the ...
(Date:5/6/2015)... Qushanna Doby (20) was arrested for child neglect, after ... Florida while under the influence of Flakka, according to ... by CBS4’s Peter D’Oench records Doby distraught in a parking ... one year old. The drug treatment center in Florida who ... The residents polled by CBS Miami express concern about the ...
(Date:5/6/2015)... The Canton Group is joining Lardarius Webb ... annual charity softball game. The event takes place on Friday, ... Past years guests include Joe Flacco, John Harbaugh, Ed Reed ... sale if you are interested in attending. , The ... as SOAR Baltimore and The CollegeBound Foundation ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 TMG Health, ... to the Medicare Advantage, Medicare Part D and Managed ... Continuity and Resilience Team category at the BCI North ... Institute to recognize the outstanding contribution of business continuity ... North America Region, including the USA and Canada. The ...
Breaking Medicine News(10 mins):Health News:RPS Revolution Launches Kickstarter Campaign 2Health News:RPS Revolution Launches Kickstarter Campaign 3Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 2Health News:The Canton Group Sponsors Ravens Charity Softball Event 3Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3
... , OMAHA, Neb. and PHOENIX, Ariz., June 30 ... Joseph,s Hospital and Medical Center in Phoenix today announced an ... school presence in Phoenix. , , The Phoenix ... School of Medicine at St. Joseph,s Hospital and Medical Center, ...
... infection to treat and requires six months of multiple ... pandemic, a shorter and simpler drug treatment would be ... settings with poor public health infrastructures. ... which TB patients could benefit from shorter treatment, researchers ...
... Community Improvement , , MINNEAPOLIS, June 30 ... and a leader in financial clearing services for health ... the Ernst & Young Entrepreneur Of The Year(R) 2009 ... region. According to Ernst & Young LLP, the award ...
... Partnership to Fight Chronic Disease (PFCD), a coalition committed to ... comprehensive health reform, hosted a breakfast meeting today where partner ... and care. , , America spends more ... percent - or $1.7 trillion - of that spending is ...
... Ultrasound in Medicine (AIUM) has reached a management ... (ISTU) effective July 1, 2009. The AIUM will ... functions in an effort to maximize the ISTU,s ... "The AIUM recognizes therapeutic ultrasound as a ...
... 30 /PRNewswire/ - Winnipeg-based medical device company Intelligent ... Century Achievement Award during the Computerworld Honors Program ... D.C. IH Systems received the award in recognition ... world,s first solution combining software, robotics and engineering ...
Cached Medicine News:Health News:Creighton University, St. Joseph's Hospital and Medical Center Announce New School of Medicine Campus in Phoenix 2Health News:Measurements fail to identify TB patients who could benefit from shorter treatment course 2Health News:SearchAmerica(R) President, Daniel Johnson, Named Ernst & Young Entrepreneur Of The Year(R) 2Health News:SearchAmerica(R) President, Daniel Johnson, Named Ernst & Young Entrepreneur Of The Year(R) 3Health News:Delaware's Partnership to Fight Chronic Disease Breakfast Highlights Promising Practices in Managing Chronic Disease Provides Solutions for Reduced Spending and Improved Patient Health 2Health News:Intelligent Hospital Systems Receives International Award for Innovative Technology Benefiting Society 2
... matrix constructed of cross-linked collagen fibers ... through a proprietary 360 accretion process. ... aspirate, Healos provides an excellent environment ... differentiation. The hydroxyapatite-coated collagen microfibers in ...
Sharp Weitlaner Retractor....
Weitlaner retractor, blunt....
Bruns (Volkmann) bone curette, with Novotex plastic handle (autoclavable in autoclave up to 143C by 3 bar), 9, oval....
Medicine Products: